Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00489791 + Pregabalin in Post-Herpetic Neuralgia
NCT00599638Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF-00489791 in postherpetic neuralgia (PHN), sponsored by Pfizer. Started Apr 2008; status: completed.
02
Drugs
PF-00489791
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00599638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599638.